Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Liangliang Qiao
Institution:
Guangzhou University of Chinese Medicine
Observed institution:
Guangzhou University of Chinese Medicine
ORCID:
0009-0009-4451-6854
Observed ORCID:
0009-0009-4451-6854
OpenAlex ID:
A5000245556
Lenvatinib Combined With Transarterial Chemoembolization as First-Line Treatment for Advanced Hepatocellular Carcinoma: A Phase III, Randomized Clinical Trial (LAUNCH)
2022
·
Zhenwei Peng
, Wenzhe Fan
, et al.
·
Journal of Clinical Oncology
·
505
Survival in Patients With Recurrent Intermediate-Stage Hepatocellular Carcinoma
2024
·
Wenzhe Fan
, Bowen Zhu
, et al.
·
JAMA Oncology
·
68
Sintilimab plus bevacizumab combined with radiotherapy as first-line treatment for hepatocellular carcinoma with portal vein tumor thrombus: A multicenter, single-arm, phase 2 study
2024
·
Meiyan Zhu
, Zelong Liu
, et al.
·
Hepatology
·
66
Adjuvant Transarterial Chemoembolization With Sorafenib for Portal Vein Tumor Thrombus: A Randomized Clinical Trial
2024
·
Zhenwei Peng
, Wenzhe Fan
, et al.
·
JAMA Surgery
·
27
PDF
Adjuvant Chemoradiation and Immunotherapy for Extrahepatic Cholangiocarcinoma and Gallbladder Cancer: A Randomized Clinical Trial
2025
·
Han Xiao
, Jiansong Ji
, et al.
·
JAMA Oncology
·
26
Idarubicin‐Loaded DEB‐TACE plus Lenvatinib versus Lenvatinib for patients with advanced hepatocellular carcinoma: A propensity score‐matching analysis
2022
·
Wenzhe Fan
, Bowen Zhu
, et al.
·
Cancer Medicine
·
22
Case report: Cryoablation as a novel bridging strategy prior to CAR-T cell therapy for B cell malignancies with bulky disease
2023
·
Xiaomin Zhang
, Jinming Wu
, et al.
·
Frontiers in Oncology
·
11
Idarubicin versus Epirubicin in Transarterial Chemoembolization for Barcelona Clinic Liver Cancer Stage B Hepatocellular Carcinoma: An Open-label, Randomized, Phase IV Trial
2025
·
Haikuan Liu
, Wenzhe Fan
, et al.
·
Radiology
·
10
Identifying optimal candidates for post-TIPS patients with HCC undergoing TACE: a multicenter observational study
2022
·
Wenzhe Fan
, Bowen Zhu
, et al.
·
European Radiology
·
10
PDF
DEB ‐ TACE versus cTACE for unresectable HCC with B1 ‐type bile duct invasion after successful biliary drainage: A propensity score matching analysis
2024
·
Wenzhe Fan
, Xinlin Zheng
, et al.
·
Cancer Medicine
·
7
PDF
Sorafenib plus drug-eluting bead transarterial chemoembolization for early intrahepatic stage-progressed advanced hepatocellular carcinoma refractory to conventional transarterial chemoembolization
2022
·
Wenzhe Fan
, Bowen Zhu
, et al.
·
Journal of Cancer Research and Clinical Oncology
·
4
PDF
Prediction Model of Survival in Unresectable HCC with Central Bile Duct Invasion Receiving TACE After Biliary Drainage: TEMP Score
2025
·
Wenzhe Fan
, Xinlin Zheng
, et al.
·
Journal of Hepatocellular Carcinoma
·
3
PDF
The characteristics and clinical relevance of tumor fusion burden in non-EBV (+) gastric cancer with MSS
2023
·
Yongjun Zhu
, Weixin Wu
, et al.
·
BMC Gastroenterology
·
3
PDF
Evaluation of surrogate endpoints in phase III randomized control trials of advanced hepatocellular carcinoma treated with immune checkpoint inhibitors
2025
·
Ke Jiang
, Miaowen Liu
, et al.
·
European Journal of Clinical Pharmacology
·
2
Show more works
View as search
Works count:
14
Citation count:
764
H-index:
9
I10-index:
9
Year
Topic
Type